| State | Name as filed |
|---|---|
| CA | Quest Diagnostics Incorporated |
| State | Agency | Source key | Raw status | Status | Stage | Review type |
|---|---|---|---|---|---|---|
| CA | Office of Health Care Affordability (HCAI) | material-change-transaction-notice-quest-diagnostics-incorporated | CMIR Waived | WAIVED | NOTICE | Quest Diagnostics Incorporated will acquire laboratory assets and services from two of Fresenius Medical Care Holdings, Inc.’s subsidiaries, Spectra East, Inc. and Spectra Laboratories, Inc. |
| Date | Date kind | Event | Raw text | Source |
|---|---|---|---|---|
| 2025-05-28 | PUBLISHED | NOTICE_ACCEPTED | Date Submission Completed: May 28, 2025 | CA agency page |
| not dated | PUBLISHED | CMIR_WAIVED | CMIR Waived | CA agency page |
| Source | Captured at (UTC) |
|---|---|
| https://hcai.ca.gov/affordability/ohca/assess-market-consolidation/material-change-transaction-notices-mcn-and-cost-and-market-impact-review-cmir/ | 2026-09-26T11:15:42.293Z |